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AcceptedSchizophrenia poses an evolutionary-genetic paradox because it exhibits strongly negative fitness effects
and high heritability, yet it persists at a prevalence of approximately 1% across all human cultures. Recent
theory has proposed a resolution: that genetic liability to schizophrenia has evolved as a secondary
consequence of selection for human cognitive traits. This hypothesis predicts that genes increasing the risk
of this disorder have been subject to positive selection in the evolutionary history of humans and other
primates. We evaluated this prediction using tests for recent selective sweeps in human populations and
maximum-likelihood tests for selection during primate evolution. Significant evidence for positive
selection was evident using one or both methods for 28 of 76 genes demonstrated to mediate liability to
schizophrenia, including DISC1, DTNBP1 and NRG1, which exhibit especially strong and well-replicated
functional and genetic links to this disorder. Strong evidence of non-neutral, accelerated evolution was
found for DISC1, particularly for exon 2, the only coding region within the schizophrenia-associated
haplotype. Additionally, genes associated with schizophrenia exhibited a statistically significant
enrichment in their signals of positive selection in HapMap and PAML analyses of evolution along the
human lineage, when compared with a control set of genes involved in neuronal activities. The selective
forces underlying adaptive evolution of these genes remain largely unknown, but these findings provide
convergent evidence consistent with the hypothesis that schizophrenia represents, in part, a maladaptive
by-product of adaptive changes during human evolution.
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Schizophrenia is characterized by delusions and auditory
hallucinations, loss of coherence and logic in thought and
language, and emotionality inappropriate to social context
(Crow 1997; Horrobin 1998; Tamminga & Holcomb
2005). This disorder has a polygenic basis involving
multiple genes of small effect (Riley & Kendler 2006), and
its phenotypic effects represent one end of a continuum
that grades into schizotypal cognition and to normality
(Rossi & Daneluzzo 2002; Mata et al. 2003).
Schizophrenia has also been associated with creativity
throughout recorded history (Claridge et al. 1990; Nettle
2001). Diverse evidence from psychological experiments,
biographical survey studies and neurophysiology has been
accumulating for many years in support of the hypothesis
that schizotypal cognition is associated with creativity and
divergent thinking (see reviews in Claridge et al. 1990;
Nettle 2001, 2006a; Barrantes-Vidal 2004). An untested
prediction of this hypothesis is that schizophrenia has
evolved, and is maintained, in part as a maladaptive
by-product of recent positive selection and adaptive
evolution in humans (Crow 1997; Horrobin 1998).
To assess the hypothesis that genes associated with
schizophrenia have been subject to positive selection, we
analysed the molecular evolution of 76 genes, which haveic supplementary material is available at http://dx.doi.org/10.
b.2007.0876 or via http://www.journals.royalsoc.ac.uk.
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2801been inferred to increase schizophrenia risk. We used two
complementary approaches. First, we used linkage
disequilibrium-based methods to test for signatures of
recent selective sweeps, which involve relatively large
coding and non-coding genomic regions (extended
haplotypes) inferred to have recently and rapidly increased
in frequency in human ancestry, such that they have not
yet been broken up by recombination (Biswas & Akey
2006; Sabeti et al. 2006; Voight et al. 2006). Second, we
employed phylogeny-based maximum-likelihood methods
(Yang 1997; Zhang et al. 2005) for detecting positive
selection, in humans and related primates, which are
based on the ratio of non-synonymous to synonymous
substitution rates. We also review the literature from
previous studies on the molecular evolution of schizo-
phrenia-related genes along the human lineage.2. MATERIAL AND METHODS
(a) Criteria for inclusion of genes
Schizophrenia risk is mediated by many genes, each of small
effect. The unambiguous identification of such genes has
been difficult, because detecting small effects requires very
large samples, different combinations of alleles can mediate
liability, risk alleles often vary between populations and
schizophrenia exhibits considerable clinical heterogeneity: it
is not a simple, unitary disorder (Tamminga & Holcomb
2005; Riley & Kendler 2006). Our criterion for inclusion of
schizophrenia-linked genes was genetic association with the
disorder via association studies (comparing allele frequenciesThis journal is q 2007 The Royal Society
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family-based transmission–disequilibrium studies that test for
differential inheritance of alleles between affected and non-
affected siblings. We excluded all genes that were linked with
schizophrenia in single studies, which were subject to failed
replication attempts. The list of 76 such genes used here
(electronic supplementary material) is highly congruent with
that of Schmidt-Kastner et al. (2006) and was fully assembled
prior to our analyses.
The strength of the evidence for linkage of these genes to
the development of schizophrenia varies considerably, and it
is very likely that some proportion of these linkages will turn
out to be false positives given the history of failed replications
in this field and the high degree of clinical, genetic, gender
and ethnic heterogeneity in this disorder. We appreciate this
fact and, as this is the first analysis of its kind, we have chosen
to initially be relatively permissive in the inclusion of genes.
However, we are careful to highlight cases where evidence of
selection is observed among genes for which especially strong
and highly replicated association data exist.
We also note that the presence, in our analyses, of any
genes that are eventually shown not to be associated with
schizophrenia will make our test of enhanced positive
selection on schizophrenia-associated genes (compared with
control genes associated with neuronal activities) more,
rather than less, conservative. Indeed, with regard to this
test, the main issue at hand is whether or not the set of genes
that has been statistically linked with schizophrenia in one or
more studies is more likely to actually exhibit association with
schizophrenia than is a random sample of control genes. We
believe that this assumption is justified.(b) Tests for positive selection using the human
HapMap
Recent positive selection can usefully be inferred by the
identification of selective sweeps, whereby selection for a
specific allele causes a relatively large block of surrounding
DNA (an extended haplotype) to increase in frequency. This
method is most effective for recent selection, as recombina-
tion breaks up such extended haplotypes over time, and it can
detect selection on both coding and non-coding regions.
Voight et al. (2006) have developed tests for recent
selective sweeps in human populations using data from the
human haplotype map. For the three genotyped populations,
one European, one African and one Asian, they tested for
evidence of positive selection as indicated by the tendency of
recently selected alleles to sweep a set of tightly linked sites to
relatively high frequency. They also provide a web interface,
HAPLOTTER (hg-wen.uchicago.edu/selection/haplotter.htm),
which we used for testing the presence and significance of
selective sweeps for specific genes and sets of contiguous
genes, and for localizing inferences of selection to specific
gene regions and SNPs. Our criterion for positive selection in
these data was a probability value of 0.05 or lower for one or
more of the three populations.
To test for a statistically increased signal of positive
selection in schizophrenia-associated genes, we compared
the frequency of positive selection in the set of 76
schizophrenia-associated genes with the frequency of positive
selection in a set of 300 control genes that were derived from
the PANTHER gene-ontology category ‘neuronal activities’
(Mi et al. 2005).Proc. R. Soc. B (2007)(c) PAML analyses
Analyses of historical selection on specific lineages, using the
ratios of non-synonymous to synonymous amino acid
substitutions for coding DNA, were carried out with the
CODEML program in the PAML program package (Yang
1997; Zhang et al. 2005). This program implements
maximum-likelihood methods to estimate the ratio of non-
synonymous to synonymous substitution rates for each codon
in a gene, across an aligned set of sequences from that gene in
different species, in a phylogenetic framework (electronic
supplementary material). For the analysis of each gene, we
used estimates of the phylogenetic relationships of the specific
taxa involved using recently published phylogenetic analyses
of mammalian relationships from the literature. Only the
topological relationship among the species involved was
recorded for these trees. Initial branch-length estimates
were determined using a preliminary CODEML run with the
single u model (M0).
We obtained orthologous mammalian gene sequences for
each candidate human gene in the following manner.
Orthology information was used from the Homologene
database (release 50.1) at NCBI (http://www/ncbi.nih.gov/)
where available. Additional mammalian orthologues were
then obtained using reciprocal best BLASTP hits from the
GenBank protein database. Corresponding nucleotide
sequences were obtained and in-frame CLUSTALW alignments
of the coding regions were conducted. Aligned nucleotide
sequences were then manually converted into PAML
input files.
We used codon and branch-specific models (Zhang et al.
2005) to investigate the action of positive selection on each of
the three branches in each tree: the human lineage; the human–
chimpanzee lineage; and the basal-primate lineage, for each
gene. In some cases, the primate lineage was the same as the
human–chimpanzee lineage (i.e. no other primate sequence
was available). These three lineages were chosen a priori
because they represent periods when evolutionary changes
underlying schizophrenia are likely to have been established:
(i) at the origin of distinctive primate traits including increased
encephalization and complex social behaviour, (ii) at the origin
of large social-group sizes and complex communication in the
lineage ancestral to chimpanzees and humans, and (iii) in the
evolution of humans, the lineage expressing schizophrenia.
The human lineage is most salient for analyses of positive
selection in schizophrenia-associated genes, but the human–
chimpanzee and primate lineage may also provide useful
insights in that these lineages presumably underwent relatively
strong selection for aspects of social cognition.
For the analyses of positive selection, we used ‘model A’ as
implemented in CODEML, which detects selection on specific
codons along specified branches of a phylogenetic tree (Zhang
et al. 2005). Model A allows four categories of selection on
codon sites in a sequence: two categories (u1 and u0) with
uniform selection across all branches (u1Z1 and 0!u0!1;
estimated from the data) and two categories for which selection
pressure differs in one or a few pre-specified ‘foreground’
branches where selection is assumed to have changed. The
method finds the model with the maximum likelihood, given
the data. If the maximum-likelihood model includes a category
of sites with an uO1, then this provides evidence that positive
selection has acted on those sites along the specific lineage
analysed. To test the significance of the results, the log
likelihood of the maximum-likelihood model can be compared
to similar models lacking selection using a log-likelihood ratio
Table 1. Genes with significant evidence of selection in human populations.
gene population p localized signal (gene(s))
APC (adenomatous polyposis of colon) Asian 0.021 —
BRD1 (bromodomain-containing protein) European 0.013 —
CAPON (nitric oxide synthase-1 neuronal) European 0.036 2
CLDN5 (claudin-5) European 0.042 —
DGCR2 (DiGeorge syndrome region gene 2) Asian 0.014 2
DTNBP1a (dystrobrevin-binding protein 1) European 0.003 1
DTNBP1a African 0.044 1
ENTH (epsin 1) European 0.027 1
ERBB4 (erythroblastic leukaemia oncogene homolog 4) Asian 0.044 1
GABRA1 (g-aminobutyric acid receptor) European 0.035 1
GABRA1 Asian 0.050 1
GRM3a (glutamate receptor 3) Asian 0.005 2
PCM1 (pericentriolar material 1) European 0.049 1
PCM1 African 0.044 1
PIK3C3 (phosphatidylinositol 3-kinase) African 0.037 1
SLC6A4 (serotonin transporter) European 0.035 —
SLC6A4 Asian 0.014 —
SYNGR1 (synaptogyrin) Asian 0.031 —
a Association with schizophrenia is especially strong and well replicated.
Two genes showing significance in the PAML analyses, NOTCH4 and TNXB, were marginally non-significant in HAPLOTTER analyses
(NOTCH4: 0.094 European; TNXB: 0.06 European), and three genes showed marginal non-significance in the HAPLOTTER analysis (HOPA: 0.
060 Asian; NOGO: 0.064 African; TPH1: 0.0505 Asian).
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itself with u constrained to equal one (i.e. a category of sites
under positive selection was not allowed; MAofix test in tables
2 and 3). The asymptotic null distribution for the test is a
50 : 50 mixture of point mass 0 and c1
2 (Zhang et al. 2005).
Simulations have shown that this test is ‘slightly too liberal’, so
we also note the results for the c2-test with 1 d.f., which was
demonstrated to be ‘overly conservative’ (Zhang et al. 2005).
Our statistical tests using PAML are expected to be prone to
false-negative (rather than false-positive) results, given the
relatively small number of species that were available for
analyses (mean of 7, range 5–15; see electronic supplementary
material). For genes showing significant evidence for selection
using the LRTs, we reran the analyses with varying starting
values for the parameters k (transition: transversion ratio) and
u, to check that we had not converged on a local likelihood
peak. See electronic supplementary material for further
explanation of PAML methods.
To test for a statistically increased signal of positive
selection in schizophrenia-associated genes, we compared
the frequency of positive selection in these 76 genes with the
frequency of positive selection in 120 control genes, randomly
chosen from the total set of 300 total control genes noted
above. For these genes, the taxa analysed included human,
chimpanzee, mouse, rat, macaque, orangutan, dog and cow.
To test for any influence of gene length on the statistical
power of the PAML analysis, we used the non-parametric
Kolmogorov–Smirnov test to compare the distribution of
gene lengths between the schizophrenia-associated gene and
control gene datasets (following the removal of outliers using
Tukey’s outlier filter) and found no significant difference.3. RESULTS
(a) HapMap analyses of positive selection in recent
human evolution
HapMap-based analyses provided evidence of recent
positive selection on 14 of the genes associated with
schizophrenia (table 1 and electronic supplementaryProc. R. Soc. B (2007)material). For six of these genes, the signal of selection
was localized specifically to the focal gene, and for three
genes, only one adjacent gene also showed significance
( p!0.05). Of particular interest is the identification of a
particularly strong and localized focus of selection for
DTNBP1, which exhibits one of the strongest genetic and
functional associations with schizophrenia of any gene
analysed to date (Riley & Kendler 2006).
Of the 14 genes inferred as selected from the HapMap
data, four displayed significant evidence for recent selection
in more than one human population, while the rest were
found to be significant in only one population. This is
suggestive of extremely recent selection acting on these
genes since the time of human demographic expansion out
of Africa, and it is also generally consistent with the presence
of variation among human populations in the genetic basis of
schizophrenia (e.g. Bulayeva et al. 2007).
The proportion of schizophrenia genes inferred as
selected in HAPLOTTER (18.4%, 14 of 76) was significantly
higher than the proportion of neuronal activities control
genes inferred as selected (9.0%, 27 of 300, c2Z5.52,
pZ0.019). Similar results were obtained when we restricted
the analyses to the subset of schizophrenia genes (NZ44) for
which differences in gene expression levels or gene-associated
neuroanatomy have been documented between schizophre-
nics and controls (electronic supplementary material): 9
(20%) of 44 positively selected compared with 27 (9%) of
300 for neuronal activities controls (c2Z5.37, pZ0.02).
These statistical comparisons with control genes
indicate that schizophrenia-associated genes may show
an enriched signal of positive selection in recent human
evolution, and that the evidence of selection is often
heterogeneous across human populations. Additionally,
12 genes, AHI1, CHL1, GRIA4, GRIN2A, GRIN2B,
NOS-1, PDLIM5, PLA2G4A, RELN, SYN2, TNXB and
TPH1, exhibited non-significance in gene-wide analyses
using HAPLOTTER, but had one or more single nucleotide
polymorphisms that were inferred to have been subject to
positive selection.
Table 2. Significant maximum-likelihood results on the human lineage for genes associated with schizophrenia.
gene model u (proportion) l K2Dl p
NRG1a (neuregulin 1) MA 999 (0.050) K2010.46 — —
MAofix K2012.50 4.07 !0.05
PLP1 (proteolipid protein 1) MA 482.65 (0.004) K1630.56 — —
MAofix K1636.11 11.08 !0.01
TNXB (tenascin XB) MA 999 (0.006) K38 734.00 — —
MAofix K38 745.00 21.90 !0.01
TP53 (tumour protein p53) MA 25.38 (0.007) K5115.85 — —
MAofix K5118.93 3.78 !0.05
a Association with schizophrenia is especially strong and well replicated.
The PAML analyses also yielded a category of sites with an uO1, providing evidence that positive selection may have acted on those sites along
the specific lineage analysed, for a set of genes that did not show significance under the likelihood ratio tests. These genes, and the putatively
selected lineages, include AHI1 (human–chimpanzee), AKT1 (human), CAPON (human–chimpanzee), CCK-AR (human), CHRM5 (human–
chimpanzee), CNP (human–chimpanzee), CNTF (human), DRD4 (human–chimpanzee), DRP-2 (human), GABRP (human–chimpanzee),
GAD1 (primate), HOPA (human), GPR50 (human), GRIN2A (human and human–chimpanzee), GRIN2B (primate), GSTM1 (human),
MLC1 (human–chimpanzee), MTHFR (primate), NOTCH4 (human–chimpanzee), NT3N (human), PCM1 (human), PDLIM5 (human),
PTGS2 (human), RGS4 (human–chimpanzee), SLC6A4 (primate), SNAP29 (human) and STOP (human–chimpanzee and primate). Table 3
shows the human–chimpanzee and primate branch results.
Table 3. Significant maximum-likelihood results in the human and chimpanzee or primate lineages for genes associated with
schizophrenia.
gene lineage model u (proportion) l K2Dl p
AHI1 (Abelson helper
integration site 1)
primate MA
MAofix
14.97 (0.024) K3512.58
K3514.60
—
4.02
—
!0.05
CHRNA7 (cholinergic
receptor neuronal
nicotinic a7)
primate MA
MAofix
17.56 (0.002) K4098.03
K4099.89
—
3.72
—
!0.05
CLDN5 (claudin-5) human–chimpanzee MA
MAofix
22.91 (0.061) K1371.13
K1373.85
—
5.44
—
!0.05
COMT (catechol-O-
methyltransferase)
primate MA
MAofix
41.58 (0.013) K2914.90
K2918.90
—
8.00
—
!0.01
DISC1a (disrupted in
schizophrenia 1)
human–chimpanzee MA
MAofix
999 (0.006) K7704.50
K7709.90
—
10.88
—
!0.01
DISC1a primate MA 46.90 (0.032) K7703.50 — —
MAofix K7710.10 13.2 !0.01
NOTCH4 primate MA 294.83 (0.006) K16 523.92 — —
MAofix K16 526.56 5.26 !0.05
PLXNA2 (plexin A2) human–chimpanzee MA 999 (0.001) K12 045.56 — —
MAofix K12 049.12 7.13 !0.05
a Association with schizophrenia is especially strong and well replicated.
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in primate evolution
PAML analyses yielded significant evidence of positive
selection on four genes on the human lineage (table 2 and
electronic supplementary material). Of particular interest
is the identification of NRG1 (neuregulin 1) that shows
notably strong genetic association with schizophrenia
(Hall et al. 2006; Riley & Kendler 2006; Thomson et al.
2007). This gene shows an absence of evidence for
selective sweeps in recent human evolution (Gardner
et al. 2007), which suggests that the positive selection that
we have inferred may have taken place earlier in the human
lineage, such that selected haplotypes have been broken up
by recombination. An additional seven genes displayed
evidence of positive selection either in the human–
chimpanzee lineage, in the ancestral primate lineage
leading to humans, or in both lineages (table 3).
Overall, 11 (15%) of the 76 schizophrenia-associated
genes showed evidence of positive selection in the PAML
analyses (tables 2 and 3), compared with 10 (8.3%) of the
120 control genes analysed (c2Z1.83, pZ0.176). For theProc. R. Soc. B (2007)human lineage, a higher proportion, 4 (5.6%) of 76 of
schizophrenia-associated genes, showed evidence of
positive selection than did the control genes (none of 120;
Fisher’s exact test, pZ0.022). However, there was no such
difference for the human–chimpanzee lineage (with three
positively selected control genes versus three positively
selected schizophrenia-associated genes; Fisher’s exact
test, pO0.50), or for the primate-origin lineage (seven
positively selected control genes versus five positively
selected schizophrenia-associated genes; Fisher’s exact
test, pO0.50). If the overly conservative (Zhang et al.
2005) test using c2-test with 1 d.f. is used, then one of the
schizophrenia-associated genes, TP53, shows marginally
non-significant evidence of positive selection in the human
lineage, such that three genes show positive selection in this
lineage (Fisher’s exact test, pZ0.057).(c) Positive selection of DISC1
DISC1 (disrupted in schizophrenia), a gene with strong,
well-replicated genetic ties to this disorder (Mackie et al.
2007), was inferred as positively selected in both the
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Figure 1. Sliding-window analysis of DISC1 (disrupted in schizophrenia 1). A sliding-window analysis of DISC1 between humans
and other primates identified several localized peaks of highly accelerated evolution. The most pronounced peaks (green arrows)
co-localize to the HEP3 haplotype region, a region reproducibly shown to associate with schizophrenia. The locations of
positively selected amino acid residues are indicated by red asterisks. Of the 16 selected residues, six fall within the HEP3
haplotype. Schematic of protein interaction domains within DISC1 are provided (Morris et al. 2003). A window size of 180 bp
and a 3 bp sliding increment were used in the analysis.
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ably, this gene showed 16 amino acid sites as having
evolved under the influence of positive selection, of which
six are within the HEP3 haplotype that segregates with
schizophrenia (see figure 1 and the following; Porteous
et al. 2006). To further investigate the DISC1 coding
region in the HEP3 haplotype, we conducted a sliding-
window analysis and found a localized peak of accelerated
evolution in this region (figure 1). DISC1 thus evolved
extremely rapidly during primate evolution, with signi-
ficant evidence for acceleration in the only coding region
of the gene showing reproducible evidence of a genetic
association with schizophrenia.4. DISCUSSION
Our results provide evidence for a significantly stronger
signal of positive selection specific to the human lineage
for schizophrenia-associated genes than for a control set of
neuronal activities genes, for both the HapMap-based
analyses of recent selective sweeps and the PAML analyses
of positive selection. Furthermore, significant evidence of
positive selection was found for several genes that exhibit
some of the best-replicated and best-understood genetic
and functional associations with this disorder, including
DISC1, DTNBP1 and NRG1.
The primary, non-exclusive implications of these
results are that schizophrenia may represent, in part, a
maladaptive by-product of adaptive changes in human and
primate evolution, and that some alleles increasing liability
to the cognitive impairments associated with schizo-
phrenia may have been selected against. These hypotheses
can be evaluated by testing the same sets of polymorph-
isms for association with schizophrenia and for signatures
of positive selection or other evolutionary-genetic pro-
cesses (Mutsuddi et al. 2006). Such integrated evolution-
ary–genomic analyses will also provide a novel, powerfulProc. R. Soc. B (2007)perspective into the functions of genes, alleles and
neurological substrates that underlie the aetiology of
schizophrenia and schizotypal cognition, since positively
selected variants are expected to exhibit functional
significance. Genetic and phenotypic changes along the
human lineage are most directly salient to the evolutionary
basis of schizophrenia, but changes earlier in primate
evolution, as apparently exemplified by DISC1, may have
generated some of the basic social-cognitive substrates
that are dysregulated in this disorder.
Additional convergent evidence that selection has
impacted the evolutionary underpinnings of schizophrenia
comes from two sources. First, neurological studies have
shown that brain areas differentially dysregulated in
schizophrenia include the regions most-notably subject
to differential evolutionary change along the human
lineage (Randall 1998; Bru¨ne 2004; Burns 2006).
Second, Wayland et al. (2006) found that genes exhibiting
positive selection for differential expression between
humans and chimpanzees are differentially dysregulated
in dorsolateral prefrontal and orbitofrontal cortices of
individuals with schizophrenia (Wayland et al. 2006).
These findings link recent evolutionary changes in human
neuroanatomy and gene expression with alterations of
these phenotypes in schizophrenia and demonstrate that
the phenotype substrates of this disorder, as well as its
genetic basis, show evidence of effects from positive
selection and adaptive evolution.(a) Evidence for positive selection from
previous studies
Our maximum-likelihood protein-coding and haplotype-
based analyses probe only for a subset of the possible
signatures of selection on genes increasing liability to
schizophrenia. Moreover, these methods detect signals
over different time scales, and for different types of
2806 B. Crespi et al. Evolution of genes underlying schizophreniapositively selected variants, such that the general absence
of concordance of genes identified as selected between the
two types of method (HapMap and PAML) is not
unexpected. For example, the great majority of positively
selected alleles in humans and other mammals are
non-coding (Williamson et al. 2007; Resch et al. 2007),
such that recent selective sweeps are expected to involve
mainly non-coding regions that will be detected only by
analyses based on HapMap data.
Given that selection involving only one or few amino
acid sites, selective sweeps older than HapMap data can
distinguish, or balancing selection that maintains human
polymorphisms, may have influenced the genetic archi-
tecture of schizophrenia, we also reviewed the literature
for evidence of selection or rapid evolution of genes
associated with schizophrenia risk, from previous studies.
Sixteen genes that exhibit genomic and functional links
with schizophrenia, ADCYAP1, AHI1, APOE, CCR5,
DRD4, DTNBP1, FOXP2, GABRB2, GRM3, HOPA,
LRRTM1, MAOA, MCPH1, OLIG2, PDLIM5 and
SLC6A4, also show evidence of positive or balancing
selection in the human lineage from previous published
studies, and five genes, CHRM5, GRIK4, ENTH, HLA-
DRB and NPAS3, show evidence of rapid evolution
(table 4 and electronic supplementary material). Further-
more, Voight et al. (2006) noted an unusual preponder-
ance of phosphatidylinositol 3-kinase signal-transduction
pathway genes subject to recent selective sweeps, and
evidence from functional analyses, physiology, pharma-
cology and genetic-association studies indicates that
dysregulated activation of this pathway (via effects of
genes such as AKT1, DTNBP1, ENTH, ERBB4, NRG1,
PIK3C3 and RELN ) represents an important risk factor
for schizophrenia (Kalkman 2006). Finally, the schizo-
phrenia-related dopamine receptor genes DRD2, DRD3
and DRD4 exhibit heterosis in some of their effects
on human physiology and behaviour (Comings &
MacMurray 2000). These findings provide additional
evidence for selection and rapid evolution of genes
underlying schizophrenia, which is generally concordant
with the results from PAML and HapMap analyses and
localizes signatures of selection to the human lineage.
(b) Potential mechanisms mediating the evolution
of genes that underlie schizophrenia
Positive selection of genes implicated in schizophrenia
may be mediated by an array of neurodevelopmental,
neurophysiological and psychological mechanisms. Our
analyses provide complementary types of evidence for
positive selection of genes underlying this disorder, but do
not provide any direct information concerning how
selective pressures at the phenotypic level may have
impacted the evolution of these genes.
Evidence from previous work salient to the hypothesis
that the adaptive evolution of genes underlying schizo-
phrenia has involved phenotypic selection comes from
studies of genetic linkages between schizophrenia-risk
genes and aspects of creativity. Allelic variants of three
genes associated with schizophrenia, SLC6A4, TPH1 and
DRD2, have recently been associated with measures
of creativity and imagination in normal population
(Bachner-Melman et al. 2005; Reuter et al. 2006).
Notably, the STin2.12 allele of an intronic polymorphism
in the SLC6A4 gene and the A allele of the A779CProc. R. Soc. B (2007)polymorphism in the TPH1 gene are each associated with
both increased creativity and increased risk of schizophrenia
(Bachner-Melman et al. 2005; Reuter et al. 2006). Alleles of
several genes associated with schizophrenia also influence
measures of schizotypal cognition and ‘openness to
experience’ in non-clinical populations, including COMT
and HTR2A (Ott et al. 2005), MAOA (Samochowiec et al.
2004) and SLC6A4 (Golimbet et al. 2003). Description of
the linkages of creativity and cognition with schizotypy and
schizophrenia is provided for the four genes, SLC6A4,
TPH1, COMT and DRD2, with sufficient integrative
information available for detailed analysis (electronic
supplementary material). We also describe here the
neurological and psychological evidence that links schizo-
typy with aspects of creativity and divergent thinking, and
epidemiological data for variation in measures of fitness
between schizophrenics, first-order relatives and controls.
The mechanisms connecting schizotypal cognition and
creativity with postulated fitness benefits are unclear, but
may include sexual selection, creative and artistic skills, or
general benefits from insight problem solving (Shaner et al.
2004; Nettle 2006a; Karimi et al. 2007). Such processes
could potentially help to explain the paradoxical high
heritability and persistence of schizophrenia, owing to
some combination of multilocus balancing selection,
antagonistic pleiotropy affecting fitness and mutation–
selection balance.
We stress that enhanced creativity is not expected to be
a function of schizophrenia itself (which involves profound
cognitive impairments), but rather is inferred to be a
function of schizotypal cognition (Claridge et al. 1990;
Nettle 2001, 2006a,b; Barrantes-Vidal 2004). Indeed,
alleles underlying the deleterious aspects of schizophrenia
or schizotypal cognition are expected to be selected against
(Keller & Miller 2006; Nettle 2006b). We also note that
most studies of the cognitive correlates of genetic liability
to schizophrenia have focused on documenting deficits in
clinical populations, rather than testing for potentially
positive aspects of cognition in healthy relatives or
other individuals who carry schizophrenia-associated
alleles or genotypes.
(c) Limitations and implications
Interpretation of our results is limited by the observation
that few of the genes associated with increased schizo-
phrenia risk are specific to this disorder: some such genes
are also known to affect liability to bipolar disorder, and
most of them influence a diverse range of neurodevelop-
mental and physiological processes, and exert only a small
effect on schizophrenia risk that may vary among
populations (Kendler 2005; Riley & Kendler 2006).
Bipolar disorder and schizophrenia in particular exhibit
substantial overlap in cognitive symptoms as well as their
genetic basis, and links of bipolar disorder with creativity
and imagination have also been repeatedly described
(Claridge et al. 1990; Nettle 2001).
A second limitation of our study is that there remains
considerable controversy about what constitutes adequate
statistical demonstration of association between allelic
variants of a specific gene and schizophrenia. Taking the
most conservative approach on this question would result
in too few genes for any meaningful analyses, whereas
including all genes that have ever been linked with
schizophrenia in a single study or population would be
Table 4. Evidence for selection and rapid evolution of genes associated with schizophrenia from previous studies.
gene evidence of selection references
ADCYAP1 (adenylate cyclase-activating
polypeptide 1)
positive selection Bustamante et al. (2005); Wang et al.
(2005); Hashimoto et al. (in press)
AHI1 (Abelson helper integration site 1) rapid evolution; positive selection Ferland et al. (2004);
Amann-Zalcenstein et al. (2006)
APOE (apolipoprotein E) positive and balancing selection Fullerton et al. (2000); Finch & Stanford
(2004); Xu et al. (2006)
CCR5 (chemokine, C–C motif, receptor 5) balancing selection Bamshad et al. (2002); Wooding et al.
(2005); Geroldi et al. (2006);
Rasmussen et al. (2006)
CHRM5 (cholinergic receptor muscarinic 5) rapid evolution in primate
compared with rodents
Dorus et al. (2004)
DRD4 (dopamine receptor D4) selective sweep (approx. 40 000 yrs
ago)
Ding et al. (2002); Lung et al. (2002);
Jo¨nsson et al. (2003a); Wang et al.
(2004)
DTNBP1a (dystrobrevin-binding protein 1) haplotype structure suggests
positive selection
van den Oord et al. (2003); Williams et al.
(2005); Riley & Kendler (2006);
Tochigi et al. (2006)
ENTH (epsin 1) nearest gene to human-accelerated
genomic region
Pollard et al. (2006); Tang et al. (2006);
Gurling et al. (2007)
FOXP2 (forkhead box P2) positive selection Enard et al. (2002); Zhang et al. (2002);
Sanjua´n et al. (2006)
GABRB2 (g-aminobutyric acid receptor b2) positive selection Lo et al. (2007a,b)
GRIK4 (glutamate receptor ionotropic
kainate 4)
rapid evolution in primate
compared to rodents
Dorus et al. (2004); Pickard et al. (2006a)
GRM3 (glutamate receptor metabotropic 3) selective sweep Diller et al. (2002); Egan et al. (2004);
Chen et al. (2005)
HLA-DRB (major histocompatibility
complex, class II, DR b-5)
rapid evolution Bergstro¨m et al. (1998); Wright et al.
(2001); Hohjoh et al. (2003)
HOPA (mediator of RNA polymerase II
transcription)
selective sweep; positive selection DeLisi et al. (2000); Philibert et al. (2001,
2007); Spinks et al. (2004);
Bustamante et al. (2005)
LRRTM1 (leucine-rich repeat
transmembrane protein 1)
selective sweep Voight et al. (2006); Laure´n (2007);
Francks et al. (in press)
MAOA (monoamine oxidase A) selective sweep Balciuniene et al. (2001); Gilad et al.
(2002); Jo¨nsson et al. (2003b); Andre´s
et al. (2004)
MCPH1 (microcephalin 1) positive selection Evans et al. (2004, 2005); Wang & Su
(2004); Lencz et al. (2007)
NPAS3 (neuronal PAS domain protein 3) nearest gene to human-accelerated
genomic region
Pickard et al. (2006b); Pollard et al.
(2006)
OLIG2 (oligodendrocyte transcription
factor 2)
selective sweep Wright et al. (2001); Diller et al. (2002);
Georgieva et al. (2006)
PDLIM5 (PDZ and LIM domain 5) positive selection Bustamante et al. (2005); Kato et al.
(2005); Horiuchi et al. (2006)
SLC6A4 (solute carrier family 6; serotonin
transporter)
positive selection Bustamante et al. (2005)
a Association with schizophrenia is especially strong and well replicated.
Detailed information on evidence for selection, linkages to schizophrenia and cognitive effects of each gene is provided in the electronic
supplementary material. Prabhakar et al. (2006) also reported evidence for accelerated evolution of CHL1, ERBB4, GRIK4, GRM8, LRRTM1
and QKI genes in the human lineage, involving human-specific substitutions in non-coding regions directly adjacent to these genes.
Evolution of genes underlying schizophrenia B. Crespi et al. 2807relatively liberal, although it would not be expected to bias
analytic results towards a finding of an enhanced signal of
positive selection, relative to control genes. We have taken
a middle ground and used genes that have not been subject
to failed replication attempts. However, it is important to
note that significant evidence for selection was found in
multiple genes showing the strongest, best-replicated
associations with schizophrenia to date, including
DISC1, DTNBP1 and NRG1. We have also repeated the
HapMap analyses using only the 44 genes for which
expression or gene-associated neuroanatomy differences
have been recorded between schizophrenics and controls,
and found the same results.Proc. R. Soc. B (2007)An important implication of our findings is that
evolutionary–genomic analyses can provide novel insights
into the nature and functions of the genes that underlie the
aetiologies of schizophrenia. More generally, analyses that
probe for signatures of selection on genes implicated in
schizophrenia may localize functional sites affecting gene
expression, enzyme activity, neurocognitive phenotypes and
disease risk, and thus highlight potential allelic variants
salient to the cognitive changes that have driven the origin of
modern humans (Crow 1997; Horrobin 1998).
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